|
See related Yaz film-coated tab information |
|
|
|
Manufacturer |
Bayer HealthCare Pharma |
|
Distributor |
DKSH |
|
Contents |
24 active tab each containing Drospirenone 3 mg, ethinylestradiol (as betadex clathrate) 0.02 mg, plus 4 inert tab |
|
Indications |
OC. Treatment of moderate acne vulgaris & premenstrual dysphoric disorder (PMDD).
Click to view Yaz detailed prescribing infomation |
|
Dosage |
1 tab daily for 28 consecutive days starting on 1st day of menstrual bleeding.
Click to view Yaz detailed prescribing infomation |
|
Overdosage |
View Yaz overdosage for action to be taken in the event of an overdose. |
|
Administration |
May be taken with or without food (Take at the same time each day. ). |
|
Contraindications |
Venous or arterial thrombotic/thromboembolic events or CVA, prodromi of a thrombosis, migraine, DM, pancreatitis associated w/ severe hypertriglyceridemia, severe hepatic disease or renal insufficiency, liver tumors, sex steroid-influenced malignancies, undiagnosed vag bleeding, pregnancy.
Click to view Yaz detailed prescribing infomation |
|
Special Precautions |
Circulatory disorders, tumors, renal impairment, hypertriglyceridemia, HTN, cholestatic jaundice.
Click to view Yaz detailed prescribing infomation |
|
Adverse Drug Reactions |
Nausea, abdominal pain, wt increased, headache, depressed or altered mood, breast pain or tenderness.
View ADR Monitoring Form |
|
Drug Interactions |
Phenytoin, barbiturates, primidone, carbamazepine, rifampicin, ritonavir, nevirapine, penicillins, tetracyclines. May increase serum K esp w/ AIIA, K-sparing diuretic, aldosterone antagonist.
View more drug interactions with Yaz |
|
Storage |
View Yaz storage conditions for details to ensure optimal shelf-life. |
|
Description |
View Yaz description for details of the chemical structure and excipients (inactive components). |
|
Mechanism of Action |
View Yaz mechanism of action for pharmacodynamics and pharmacokinetics details. |
|
